Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arata Azuma

Showing results (151-160 of 221) with videos related to

Pageof 23
Sort By:
Annals of the Rheumatic Diseases|August 16, 2022
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
American Journal of Respiratory Cell and Molecular Biology|November 24, 2004
Interferon-{beta} inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-{beta} and thrombospondinArata Azuma, Ying Ji Li, Shinji Abe, et al.
Respiratory Investigation|June 1, 2023
Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosisYasuhiko Nishioka, Sakae Homma, Takashi Ogura, et al.
Respiratory Research|July 16, 2011
The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trialHiroyuki Taniguchi, Yasuhiro Kondoh, Masahito Ebina, et al.
Human Genetics|October 29, 2010
Molecular cloning of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitisMinako Hijikata, Ikumi Matsushita, Goh Tanaka, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|July 18, 2006
[A case of multicentric Castleman disease showing diffuse cystic change in the lung]Takahito Nei, Takemitsu Oiwa, Yoshinobu Saitoh, et al.
Respiratory Investigation|November 2, 2015
Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in JapanYoshio Taguchi, Masahito Ebina, Seishu Hashimoto, et al.
The Clinical Respiratory Journal|February 18, 2015
An exploratory trial of intravenous immunoglobulin therapy for idiopathic pulmonary fibrosis: a preliminary multicenter reportNoriyuki Enomoto, Kingo Chida, Takafumi Suda, et al.
The Annals of Occupational Hygiene|January 11, 2005
Occupational and environmental factors and idiopathic pulmonary fibrosis in JapanYoshihiro Miyake, Satoshi Sasaki, Tetsuji Yokoyama, et al.
Annals of Nutrition & Metabolism|December 8, 2004
Vegetable, fruit, and cereal intake and risk of idiopathic pulmonary fibrosis in JapanYoshihiro Miyake, Satoshi Sasaki, Tetsuji Yokoyama, et al.
Pageof 23

Showing results (151-160 of 221) with videos related to

Sort By:
Pageof 23
Annals of the Rheumatic Diseases|August 16, 2022
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
American Journal of Respiratory Cell and Molecular Biology|November 24, 2004
Interferon-{beta} inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-{beta} and thrombospondinArata Azuma, Ying Ji Li, Shinji Abe, et al.
Respiratory Investigation|June 1, 2023
Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosisYasuhiko Nishioka, Sakae Homma, Takashi Ogura, et al.
Respiratory Research|July 16, 2011
The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trialHiroyuki Taniguchi, Yasuhiro Kondoh, Masahito Ebina, et al.
Human Genetics|October 29, 2010
Molecular cloning of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitisMinako Hijikata, Ikumi Matsushita, Goh Tanaka, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|July 18, 2006
[A case of multicentric Castleman disease showing diffuse cystic change in the lung]Takahito Nei, Takemitsu Oiwa, Yoshinobu Saitoh, et al.
Respiratory Investigation|November 2, 2015
Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in JapanYoshio Taguchi, Masahito Ebina, Seishu Hashimoto, et al.
The Clinical Respiratory Journal|February 18, 2015
An exploratory trial of intravenous immunoglobulin therapy for idiopathic pulmonary fibrosis: a preliminary multicenter reportNoriyuki Enomoto, Kingo Chida, Takafumi Suda, et al.
The Annals of Occupational Hygiene|January 11, 2005
Occupational and environmental factors and idiopathic pulmonary fibrosis in JapanYoshihiro Miyake, Satoshi Sasaki, Tetsuji Yokoyama, et al.
Annals of Nutrition & Metabolism|December 8, 2004
Vegetable, fruit, and cereal intake and risk of idiopathic pulmonary fibrosis in JapanYoshihiro Miyake, Satoshi Sasaki, Tetsuji Yokoyama, et al.
Pageof 23